1 |
Huang YJ, Tung WC, Hsu HC, Wang CY, Huang EY, Fang FM. Radiation therapy to non-iatrogenic subcutaneous metastasis in hepatocellular carcinoma: results of a case series. Br J Radiol 2008;81:143-50.
DOI
ScienceOn
|
2 |
Jung SM, Jang JW, You CR, et al. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol 2012;27:684-9.
DOI
ScienceOn
|
3 |
Seong J, Koom WS, Park HC. Radiotherapy for painful bone metastases from hepatocellular carcinoma. Liver Int 2005;25: 261-5.
DOI
ScienceOn
|
4 |
Niibe Y, Kenjo M, Kazumoto T, et al. Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma : 84 subjects of a population of more than 5,000. Int J Radiat Oncol Biol Phys 2006;66:1366-9.
DOI
ScienceOn
|
5 |
Niibe Y, Kuranami M, Matsunaga K, et al. Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence. Anticancer Res 2008; 28(6B):3929-31.
|
6 |
Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med 2007;356:2399-405.
DOI
ScienceOn
|
7 |
Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 2010;40:107-11.
DOI
ScienceOn
|
8 |
Koukourakis MI, Papadopoulou A, Kyrgias G. Long-term survival of a patient with multiple abdominal metastasis from endometrial carcinoma treated with multi-portal conformal re-irradiation and chemotherapy. Hematol Oncol Stem Cell Ther 2011;4:45-7.
DOI
ScienceOn
|
9 |
Yun HG. A case report of a gastric cancer patient with a good quality of life after radiotherapies to 17 metastases for 4 years. J Korean Soc Ther Radiol Oncol 2011;29:127-33.
DOI
ScienceOn
|
10 |
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14.
DOI
ScienceOn
|
11 |
Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011;117:4475-83.
DOI
ScienceOn
|
12 |
Taura N, Hamasaki K, Nakao K, et al. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:1177-83.
DOI
ScienceOn
|
13 |
Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703.
DOI
ScienceOn
|
14 |
Uka K, Aikata H, Takaki S, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J GastroenteroI 2007;13:414-20.
DOI
|
15 |
Natsuizaka M, Omura T, Akaike T. et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005;20:1781-7.
DOI
ScienceOn
|
16 |
Zachau L, Zeckey C, Schlue J, et al. Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood. World J Surg OncoI2012;10:98.
DOI
|
17 |
Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91.
DOI
ScienceOn
|
18 |
Kim HY, Park JW, Nam BH, et al. Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatme nts. J Gastroenterol Hepatol 2011;26:1612-8.
DOI
ScienceOn
|